Product Overview
[Drug Name]
Generic Name: Ligustrazine Phosphate Tablets
Trade Name: Livzon
English Name: Ligustrazine Phosphate Tablets
Chinese Pinyin: Linsuan Chuanxiongqinpian
[Ingredients]
The main ingredient of this product is ligustrazine phosphate, chemically known as 2,3,5,6-tetramethylpyrazine phosphate.
[Properties]
This product is a sugar-coated tablet, which appears white or off-white after removal of the sugar coating.
[Indications]
For ischemic cerebrovascular disease, such as cerebral infarction caused by insufficient cerebral blood flow, cerebral thrombosis, and cerebral embolism.
[Dosage and Administration]
Oral administration. 50-100 mg three times daily for one month as a course of treatment, as directed by a physician.
[Adverse Reactions]
Occasionally, stomach discomfort, dry mouth, and drowsiness may occur. Taking the tablet after meals can avoid or reduce these side effects.
[Contraindications]
This product is contraindicated in patients with cerebral hemorrhage or a predisposition to bleeding.
[Precautions]
Use with caution in patients with cerebral edema or minor hemorrhage who are unable to differentiate from ischemic cerebrovascular disease.
[Use in Special Populations]
Precautions for children:
Unknown.
Precautions for pregnancy and lactation:
Use with caution in pregnant or lactating women.
Precautions for the elderly:
Unknown.
[Drug Interactions]
This product is highly acidic and should not be used with alkaline medications.
[Pharmacological Actions]
Ligustrazine phosphate has antiplatelet aggregation, dilates arterioles, improves microcirculation, and promotes blood circulation and blood stasis. It also has a disaggregating effect on aggregated platelets.
[Storage] Store in a sealed container away from light.
[Strength] 50mg
[Packaging Specifications] 100 tablets per bottle.
[Expiration Period] 24 months
[Approval Number] National Medicine Standard H44024348
[Manufacturer] Company Name: Livzon Group Limin Pharmaceutical Factory
